[et_pb_section fb_built=”1″ _builder_version=”4.9.4″ _module_preset=”default” da_is_popup=”off” da_exit_intent=”off” da_has_close=”on” da_alt_close=”off” da_dark_close=”off” da_not_modal=”on” da_is_singular=”off” da_with_loader=”off” da_has_shadow=”on” da_disable_devices=”off|off|off”][et_pb_row _builder_version=”4.9.4″ _module_preset=”default”][et_pb_column _builder_version=”4.9.4″ _module_preset=”default” type=”4_4″][et_pb_video src=”https://youtu.be/s3j3kJFEmjQ” _builder_version=”4.9.4″ _module_preset=”default” hover_enabled=”0″ sticky_enabled=”0″ border_radii=”on|5px|5px|5px|5px” border_color_all=”#E02B20″ border_width_all=”2px”][/et_pb_video][/et_pb_column][/et_pb_row][/et_pb_section]
TEXAS LAWMAKERS CONSIDER CRUCIAL DRUG PRICE TRANSPARENCY ISSUE
April 23, 2021 (updated April 23, 2021) Published by Kevin Steele
Get involved!
Comments